Partner Institutions

International Parkinson Disease Genomics Consortium (IPDGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

• NIH National Institute on Aging (NIA), United States of America (USA)
• UCL Queen Square Institute of Neurology (IoN), United Kingdom (UK)
• Université Toulouse III - Paul Sabatier (UPS), France
• University of Tübingen (Uni Tübingen), Germany
• deCODE Genetics, Iceland
• Washington University School of Medicine (WUSM), WUSTL, United States of America (USA)
• Research Center of the Brain and Spinal Cord Institute (CRISM), ICM, France
• AP-HP Pitié-Salpêtrière Hospital - Charles-Foix, France
• UCL Genetics Institute (UGI), United Kingdom (UK)
• Physiopathology Center of Toulouse-Purpan (CPTP), France
• VU University Medical Center (VUmc), Netherlands
• Pierre and Marie Curie University (UPMC) - Paris 6, France
• Landsptali University Hospital, Iceland
• Mid Essex Hospital Services NHS Trust, United Kingdom (UK)
• Addenbrooke's Hospital, United Kingdom (UK)
• University of Cambridge, United Kingdom (UK)
• University of Bristol (UoB), United Kingdom (UK)
• University of Amsterdam (UvA), Netherlands
• Massachusetts General Hospital (MGH), United States of America (USA)
• Radboud University Medical Centre (Radboudumc), RU, Netherlands
• Newcastle University, United Kingdom (UK)
• University of Birmingham (UB), United Kingdom (UK)
• University of Aberdeen, United Kingdom (UK)
• University Hospital Nantes (CHU de Nantes), France
• Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED), France
• Wellcome Trust Sanger Institute, United Kingdom (UK)
• University of Kiel (CAU), Germany
• Imperial College London (ICL), United Kingdom (UK)
• CHU Clermont-Ferrand, France
• John van Geest Centre for Brain Repair (BRC), University of Cambridge, United Kingdom (UK)
• Leiden University, Netherlands
• AARP, Inc., United States of America (USA)
• John Radcliffe Hospital, United Kingdom (UK)
• The Pennsylvania State University (Penn State), United States of America (USA)
• Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Germany
• Public Health and Molecular Epidemiology of Aging-related Diseases, France
• NIH National Human Genome Research Institute (NHGRI), United States of America (USA)
• MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG), Cardiff University, United Kingdom (UK)
• National Hospital for Neurology and Neurosurgery (NHNN), UCLH, United Kingdom (UK)
• Washington University in St. Louis (WUSTL), United States of America (USA)
• CHU de Grenoble, France
• Biogen Inc., United States of America (USA)
• Erasmus Medical Center (Erasmus MC), Netherlands
• University of Rochester (UR), United States of America (USA)
• The University of Edinburgh, United Kingdom (UK)
• Oxford Wellcome Trust Centre for Human Genetics, United Kingdom (UK)
• The Parkinson's Institute and Clinical Center (The PI), United States of America (USA)
• CHU de Bordeaux, France
• Institut Pasteur de Lille (Pasteur-Lille), France
• Sandwell and West Birmingham Hospitals NHS Trust (SWBH), United Kingdom (UK)
• University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK)
• Broad Institute of MIT and Harvard, United States of America (USA)
• German Center for Neurodegenerative Diseases within the Helmholtz Association (DZNE), Germany
• Cardiff University, United Kingdom (UK)
• King Faisal Specialist Hospital & Research Centre (KFSH&RC), Saudi Arabia
• French National Centre for Scientific Research (CNRS), France
• Queen Mary University of London (QMUL), United Kingdom (UK)